Endocrine Reviews

Papers
(The TQCC of Endocrine Reviews is 53. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome348
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway294
Papillary Craniopharyngioma: An Integrative and Comprehensive Review269
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”217
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes167
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases160
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention155
DNA Damage and Repair in Thyroid Physiology and Disease149
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future140
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies122
The Molecular Biology of Midgut Neuroendocrine Neoplasms117
Effects of Maternal Vitamin D Supplementation on Childhood Health114
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity108
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story107
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”92
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies89
Calcium-Sensing Receptor Regulation of Gastrointestinal Hormone Secretion88
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?87
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism87
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors85
Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management82
The Biology and Clinical Implications of PCSK780
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status74
Estrogen Receptor Signaling in the Immune System73
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas66
Contemporary Biological Insights and Clinical Management of Craniopharyngioma64
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review63
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia63
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”63
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction62
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance61
Steroid receptor coactivators: from basic research to translational opportunities59
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease56
Glycated CD59, a Novel Biomarker for Gestational Diabetes56
Imaging of Pheochromocytomas and Paragangliomas55
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling55
The Cortisol Awakening Response: Regulation and Functional Significance54
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases53
0.35879683494568